Records containing: Pharmacokinetics

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study results posted · 2026-08-24
  A Phase 1, Open-label Study to Evaluate the Safety and Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Adult Participants
• CLINICAL_TRIALS study results posted · 2026-08-14
  A Phase I Open-label, Placebo-controlled Dose Escalation Study to Evaluate Safety and Pharmacokinetics of Natrunix Via Subcutaneous Injection in Healthy Subjects
• CLINICAL_TRIALS study record update · 2026-07-22
  Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers: A Single-Center Randomized, Double-Blinded, Two-Treatment, Two-Period, Two-Sequence, Crossover, Hyperinsulinemia-Euglycemic Clamp Study
• CLINICAL_TRIALS study results posted · 2026-07-02
  Scavenging of Endogenous Reactive Carbonyl Species by Apple Polyphenols in Healthy Human Subjects
• CLINICAL_TRIALS study record update · 2026-04-20
  Pharmacokinetics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade in Patients During Laparoscopic Surgery
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2026-04-16
  An Open-label, Phase 1, Single Dose, Randomized, Parallel-group Study to Evaluate the Relative Bioavailability of Two Evolocumab (AMG 145) Drug Products
• CLINICAL_TRIALS study record update · 2026-04-06
  A Single Center, Two-part, Double-blind, Randomized, Placebo-controlled, Dose-escalation, Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BB-025 or Placebo, Alone and Following a Single Dose of BB-031, in Healthy Volunteers
• CLINICAL_TRIALS study record update · 2026-04-01
  A Randomized, Double-Blind, Phase 1b Study in Healthy HIV-Negative Women to Evaluate the Pharmacokinetics, Safety, and Bleeding Patterns Associated With 90-Day Use of Core-Sheath Vaginal Rings Releasing Dapivirine and Levonorgestrel
• CLINICAL_TRIALS study record update · 2026-03-06
  A Single Dose Study to Evaluate the Pharmacokinetics of Oxycodone and PF614 When PF614 Capsule is Co Administered With Nafamostat as a Combination IR Solution and ER Capsule Formulation in Healthy Subjects
• CLINICAL_TRIALS study record update · 2026-03-05
  Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar Rapid-Acting Insulin Aspart (I004) and NovoLog After Single-Dose Subcutaneous Administration to Healthy Volunteers: A Single-Center Randomized, Double-blinded, Two-Treatment, Two-period, Two-sequence Crossover, Hyperinsulinemia-Euglycemic Clamp
• CLINICAL_TRIALS study record update · 2026-02-17
  Pharmacokinetics and Pharmacodynamics of Caspofungin in Children Severe Infection
• CLINICAL_TRIALS study record update · 2026-02-10
  A Phase 1, Open-label, Single-dose Study to Assess the Influence of Hepatic Impairment on the Pharmacokinetics of of Sevabertinib (BAY 2927088)
• CLINICAL_TRIALS study record update · 2026-02-04
  A Phase 1, Open-label, Randomized, Crossover Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single Subcutaneous Dose Administration Using a Reusable ServoPen With Cartridge as Compared to Administration Using a Syringe Drawn From an Ampule
• CLINICAL_TRIALS study record update · 2026-02-04
  A Phase 1, Open-Label, Multiple Dose Study to Assess the Pharmacokinetics, Safety, Tolerability, and Food Effect of MRX1 in Healthy Adults
• CLINICAL_TRIALS study record update · 2026-01-23
  A Phase 1, Open-label Study to Evaluate the Safety and Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Adult Participants
• CLINICAL_TRIALS study record update · 2026-01-22
  A Randomized, Double-blind, Placebo-controlled Trial to Evaluate Multiple Dose Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Ascending Doses of Noribogaine in Healthy Volunteers.
• CLINICAL_TRIALS study record update · 2026-01-16
  Antibiotic Dosing in Pediatric Intensive Care
• CLINICAL_TRIALS study record update · 2026-01-16
  Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation
• CLINICAL_TRIALS study record update · 2025-12-26
  A First-in-Human, Randomized, Double-Blinded, Placebo Controlled, SAD and MAD Study in Healthy Participants to Evaluate the Safety, Tolerability, and Pharmacokinetics of YR011 Following Oral Administration.
• CLINICAL_TRIALS study record update · 2025-12-18
  A Phase 1, Open-label Study to Evaluate the Safety and to Characterize the Pharmacokinetics of a Fixed-Dose Combination Formulation of Ceftibuten-Ledaborbactam Etzadroxil
• CLINICAL_TRIALS study record update · 2025-12-09
  A Randomized, Balanced, Phase 1, Multiple-dose, Open-label, Two-treatment, Two-period, Two-sequence, Crossover, Relative Bioavailability Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects
• CLINICAL_TRIALS study record update · 2025-12-08
  VNRX-7145-104: an Open-label, Cross-over Study to Evaluate the Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Ceftibuten/VNRX-7145 in Healthy Participants.
• CLINICAL_TRIALS study record update · 2025-12-08
  VNRX-7145-103: A Phase 1, Open-label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ceftibuten/VNRX-7145 in Participants With Varying Degrees of Renal Function
• CLINICAL_TRIALS study record update · 2025-12-02
  Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment
• CLINICAL_TRIALS study record update · 2025-11-20
  Safety, Tolerability and Pharmacokinetics of Single-ascending Doses of RCS-21 in Healthy Volunteers. A Double Blind, Randomized, Placebo Controlled Phase I Study.